SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending intensely as the market anticipates whether the company will raise its bid for Warner Bros. Discovery in response to a rival offer, fueling community debate on whether pursuing the deal or walking away would best benefit the stock amidst ongoing regulatory and political scrutiny.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is surging on strong Anktiva revenue growth and a newly unveiled 3-year plan for global expansion and pipeline acceleration across multiple cancer indications, igniting community discussion around a potential short squeeze and its long-term potential in immunotherapy.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is actively in a heated bidding war for Warner Bros. Discovery (WBD) with an enhanced offer, compelling WBD to re-enter negotiations despite its current agreement with Netflix (NFLX). The community is fiercely debating whether PSKY's improved terms and perceived smoother regulatory path will ultimately win over WBD shareholders, or if the substantial debt PSKY would incur makes the acquisition untenable.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a significant sell-off, marking its worst day in over two decades, after Anthropic's Claude Code AI announced capabilities to automate COBOL modernization, fueling fears of AI disruption to legacy services. However, much of the community is debating whether the market is overreacting, pointing to IBM's existing strategic partnership with Anthropic and its robust enterprise-grade solutions that provide security and integration beyond standalone AI tools.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is surging due to a strategic collaboration with Astellas for its prostate cancer T-cell engager (VIR-5500) backed by promising Phase 1 data, an earnings beat, and an extended cash runway; however, community sentiment is split between bullish short-squeeze hopes and warnings of a typical post-news pullback.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing a dramatic sell-off, with community discussion dominated by fears that AI models pose an existential threat to its core software products, despite recent strong earnings beats and management's efforts to address these concerns.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Protara Therapeutics Inc

Protara Therapeutics is trending after releasing interim Phase 2 data for its TARA-002 bladder cancer treatment, which demonstrated a strong 6-month complete response rate, leading to widespread community discussion about whether the positive clinical results were initially misinterpreted following a recent capital raise. Investors are closely monitoring upcoming presentations for further clarity and potential upside.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending amid widespread community discussion following a research report suggesting advanced AI agents could disrupt traditional payment network revenue models by bypassing interchange fees. While some express concern over a paradigm shift, many investors are unfazed, highlighting the company's strong fundamentals, its own "Agent Pay" initiatives for AI-driven transactions, and the essential role of trust in payments as reasons to buy the dip.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending amid strong community debate over potential impacts from a proposed credit card interest rate cap and AI disruption to payment processors; however, many investors view the sell-off as an attractive buying opportunity, highlighting the company's resilient business model and strategic advancements in stablecoin settlements.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is actively discussed amid a recent clinical trial approval for Huntington's Disease and expectations of an expedited regulatory environment for rare disease treatments. The community highlights the stock's significant undervaluation given robust Elevidys sales and its promising siRNA pipeline, fueling speculation around a potential short squeeze or strategic acquisition despite current volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

State of New Jersey Common Pension Fund D Buys Shares of 12,654 Hawkins, Inc. $HWKN

State of New Jersey Common Pension Fund D purchased a new position in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) in the 3rd quarter, according to the company in its most recent filing with...

Granite Investment Partners LLC Invests $11.61 Million in Hawkins, Inc. $HWKN

Granite Investment Partners LLC purchased a new stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities...

Martin & Co. Inc. TN Has $4.11 Million Position in Hawkins, Inc. $HWKN

Martin & Co. Inc. TN reduced its stake in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 29.2% during the 3rd quarter, according to the company in its most recent filing with the Securities...

7,309 Shares in Hawkins, Inc. $HWKN Purchased by Zions Bancorporation National Association UT

Zions Bancorporation National Association UT purchased a new stake in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the...

Public Sector Pension Investment Board Acquires 16,850 Shares of Hawkins, Inc. $HWKN

Public Sector Pension Investment Board increased its holdings in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 26.1% in the third quarter, according to the company in its most recent Form 13F filing...

Hawkins, Inc. $HWKN Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. increased its stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 12.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The...

New York State Common Retirement Fund Boosts Holdings in Hawkins, Inc. $HWKN

New York State Common Retirement Fund increased its holdings in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 137.5% in the third quarter, according to its most recent 13F filing with the SEC. The...

Hawkins (NASDAQ:HWKN) Director James Faulconbridge Purchases 1,500 Shares

Hawkins, Inc. (NASDAQ:HWKN - Get Free Report) Director James Faulconbridge acquired 1,500 shares of the business's stock in a transaction that occurred on Wednesday, February 4th. The shares were...

Hawkins (NASDAQ:HWKN) Director James Faulconbridge Acquires 1,500 Shares

Hawkins, Inc. (NASDAQ:HWKN - Get Free Report) Director James Faulconbridge bought 1,500 shares of the firm's stock in a transaction dated Wednesday, February 4th. The shares were acquired at an...

Hawkins, Inc. (NASDAQ:HWKN) Given Average Rating of "Hold" by Brokerages

Hawkins, Inc. (NASDAQ:HWKN - Get Free Report) has received a consensus recommendation of "Hold" from the five research firms that are presently covering the stock, Marketbeat reports. Three analysts...

Hawkins, Inc. engages in the distribution, blending, and manufacture of chemicals and specialty ingredients for a wide variety of industries. It operates through the following segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment provides industrial chemicals, products, and services to the agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal, industrial wastewater, industrial process water, and non-residential swimming pool water. The Health and Nutrition segment consists of ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, health, and wellness products. The company was founded by Howard Hawkins in 1938 and is headquartered in Roseville, MN.

HWKN
Hawkins Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HWKN News

HWKNHawkins Inc